Acta Crystallographica, Section C: Crystal Structure Communications p. 1364 - 1365 (1999)
Update date:2022-08-11
Topics:
Ghosh, Sutapa
Uckun, Fatih M.
The title compound, C11H8Br2N2O2 (LFM-A13), is the first reported BTK-specific tyrosine kinase inhibitor and the first antileukemic agent targeting BTK (Bruton's tyrosine kinase). The crystal structur
View More
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Contact:86 311 85902108 / 85902109
Address:room 1001-1005 ,huanghe Road ,shijiazhuang ,China
Landz International Company Ltd.
Contact:0086-21-58891610
Address:985 Dongfang Road, Pudong, Shanghai 200122 China
Nanjing Vincero International Trading Co.,Ltd
Contact:8618936897229
Address:NO.68, ZhuShan Road, JiangNing WanDa Plaza, Building E Room 1703
Contact:86-511-85210668 0511-85210668, 85210818, 85210898
Address:Yihai Garden E-902,NO.99 Daxi RD., Zhenjiang Jiiangsu ,China
Doi:10.1016/0045-6535(94)90356-5
(1994)Doi:10.1016/S0040-4039(01)01335-1
(2001)Doi:10.1002/ejic.201400001
(2014)Doi:10.1039/c9tc00326f
(2019)Doi:10.1246/cl.2001.1194
(2001)Doi:10.1016/S0040-4039(00)76654-8
(1994)
